发明名称 Tetrazolyl-substituted quinuclidines as substance P antagonists
摘要 This invention provides a compound of the formula: and its pharmaceutically acceptable salts, wherein R1 is halo, C1-C6 alkyl, halo C1-C6 alkyl, C1-C6 alkoxy or halo C1-C6 alkoxy; R2 is hydrogen, C1-C6 alkyl, halo C1-C6 alkyl, C1-C6 alkyl-S-, C1-C6 alkyl-SO-, C1-C6 alkyl-SO2-, cyclopropyl, phenyl, -NH2, -NH(CH3), -NHC(=O)CH3, -N(CH3)2, -N(C2H5)2 or -CH2C(=O)CF3; Ar1 and Ar2 are independently phenyl, halophenyl or thienyl; X is NH, O or S; and Y is hydrogen, -COOR3 or -CONR4R5, wherein R3, R4 and R5 are independently hydrogen or C1-C6 alkyl. These compounds are useful as analgesics or anti-inflammatory agents, or in the treatment of allergic disorders, angiogenesis, CNS disorders, emesis, gastrointestinal disorders, sunburn, urinary incontinence, or diseases, disorders or adverse conditions caused by Helicobacter pylori, or the like, in a mammalian subject, especially human, especially as analgesics or anti-inflammatory agents in the periphery.
申请公布号 US5939434(A) 申请公布日期 1999.08.17
申请号 US19970924171 申请日期 1997.09.05
申请人 SATAKE, KUNIO 发明人 SATAKE, KUNIO
分类号 A61K31/435;A61K31/439;A61P1/00;A61P1/04;A61P1/08;A61P9/00;A61P13/00;A61P13/02;A61P15/00;A61P17/02;A61P25/00;A61P25/04;A61P25/06;A61P29/00;A61P31/04;A61P37/08;A61P43/00;C07D453/02;(IPC1-7):A61K31/44 主分类号 A61K31/435
代理机构 代理人
主权项
地址